Goldman Sachs’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-95,718
Closed -$2.42M – 6778
2026
Q1
$2.42M Buy
+95,718
New +$2.44M ﹤0.01% 4369
2025
Q4
– Sell
-44,048
Closed -$1.13M – 6604
2025
Q3
$1.13M Buy
+44,048
New +$1.12M ﹤0.01% 4949

Other funds holding IBDX

Goldman Sachs's IBDX Position: Q2 2026 in Review

Goldman Sachs sold out of iShares iBonds Dec 2032 Term Corporate ETF (IBDX) in Q2 2026, closing a stake of 95,718 shares — an estimated $2.42M sold.

Goldman Sachs first reported a position in IBDX in Q3 2025 and held it in 2 quarters. The position peaked at $2.42M in Q1 2026. 229 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Goldman Sachs reported no remaining iShares iBonds Dec 2032 Term Corporate ETF position as of Q2 2026 after selling out during the quarter.
  • Goldman Sachs sold 95,718 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $2.42M.
  • Goldman Sachs first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2025 and held it in 2 quarters.
  • Goldman Sachs's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $2.42M in Q1 2026.
  • 229 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.